US FDA Warning Letter Hits Huahai For Failure To Prevent Valsartan Contamination

 
• By Bowman Cox

Zhejiang Huahai should have realized its valsartan API was tainted by the probable carcinogen NDMA, FDA says in warning letter, despite earlier statement from agency leadership to the contrary.

FDA also trains Chinese regulators and manufacturers on techniques that promote safety. At a workshop in Zhejiang province, FDA’s Daniel Geffin showed Chinese regulators how he inspects equipment used to sterilize canned foods
Zhejiang Huahai warning letter is part of US FDA/industry dialogue that includes this canned food sterilization workshop in China's Zhejiang Province • Source: US FDA

More from Compliance

More from Pink Sheet